New hope for hard-to-treat pancreatic cancer?
Disease control
Not yet recruiting
This early-phase trial tests whether adding an experimental drug called NRT6008 to standard chemotherapy is safe and effective for people with locally advanced pancreatic cancer that cannot be removed by surgery. About 10 adults aged 18 to 85 will take part. The main goal is to c…
Phase: PHASE1 • Sponsor: NRT MedTech Australia Pty Ltd • Aim: Disease control
Last updated May 12, 2026 13:40 UTC